F 0656
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Develop and implement a complete care plan that meets all the resident's needs, with timetables and
actions that can be measured.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
review of the medical record, staff interview, and policy review, the facility failed to ensure a comprehensive
care plan was timely completed. This affected one (#100) of three residents reviewed for care planning. The
facility census was 99.
Findings include
Review of the medical record for Resident #100 revealed an admission date of 09/30/24. Diagnoses
included chronic obstructive pulmonary disease, chronic kidney disease, vascular dementia, and atrial
fibrillation.
Review of the admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident had
impaired cognition. The resident was always incontinent of bowel and bladder.
Review of the comprehensive care plan dated 10/01/24 and last revised on 10/12/24 revealed there was no
care plan in place for incontinence care.
Review of the continence task documentation from 09/30/24 through 10/22/24 revealed the resident was
always incontinent of bowel and bladder.
Interview on 10/22/24 at 7:23 A.M., Licensed Practical Nurse (LPN) #423 revealed Resident #100 was
incontinent of bowel and bladder. LPN #423 revealed the resident was unaware of when she was
incontinent.
Interview on 10/23/24 at 2:48 P.M., MDS Coordinator #367 verified there was no incontinence care plan
included in the comprehensive care plan for Resident #100. MDS Coordinator #367 revealed Resident
#100's comprehensive care plan needed to be finished. MDS Coordinator #367 verified the comprehensive
care plan should be completed within seven days of the comprehensive assessment.
Review of the policy, Comprehensive Care Plan, last revised 11/2016 revealed the comprehensive care
plan would include services that are to be furnished to attain or maintain the resident's highest practicable
physical, mental and psychosocial well-being. A comprehensive care plan must be developed within seven
days after the completion of the comprehensive assessment.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
366022
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366022
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/24/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Manor at Perrysburg
250 Manor Drive
Perrysburg, OH 43551
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
review of the medical record, staff interview, and policy review, the facility failed to ensure medications were
administered per physician orders. Additionally, the facility failed to maintain controlled substance drug
records. This affected four (#118. #24, #117, #84) of seven residents reviewed for medication
administration. The facility census was 99.
Findings include
1. Review of the medical record for Resident #118 revealed an admission date of 03/30/23 and a discharge
date of 06/26/24. Diagnoses included Alzheimer's disease with late onset, chronic obstructive pulmonary
disease, dementia, chronic kidney disease, hypertension, and chronic diastolic heart failure.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed the resident had
severe cognitive impairment.
Review of the physician orders dated 06/18/24 revealed the resident was ordered Ceftriaxone sodium
injection solution reconstituted one gram, inject one gram intramuscularly one time only for infection for one
day. There was no type of infection documented for indication of use.
Review of the medication administration record for 06/18/24 revealed the resident was administered the
incorrect antibiotic. The resident was administered cefazolin sodium injection solution reconstituted one
gram.
Review of a medication incident report dated 06/18/24 at 12:45 P.M. revealed Registered Nurse (RN) #341
administered the antibiotic cefazolin instead of the antibiotic ceftriaxone. RN #341 had signed out the
incorrect medication out of the contingency supply. The resident had no allergies to the medication and no
adverse effects were observed. The five medication rights was reviewed with the nurse.
Review of a nurse's note dated 06/18/24 at 4:20 P.M. revealed cefazolin one gram for injection given instead
of ceftriaxone one gram for injection. The nurse practitioner was notified. Will continue to monitor the
resident.
Interview on 10/24/24 at 7:35 A.M., the Director of Nursing (DON) revealed the newer nurse had pulled the
wrong medication and was educated. The DON revealed the physician was contacted. The DON verified
there was no documentation for the indication of use for the medication and the nurse was educated to
include the type of infection in the order.
2. Review of the medical record for Resident #24 revealed an admission date of 05/26/23. Diagnoses
included type two diabetes mellitus, lymphedema, heart failure, atrial fibrillation, and hypertension.
Review of the quarterly MDS assessment dated [DATE] revealed the resident had intact cognition.
Review of the physician orders dated 08/31/24 revealed an order for oxycodone-acetaminophen 10/325
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366022
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366022
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/24/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Manor at Perrysburg
250 Manor Drive
Perrysburg, OH 43551
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
milligrams (mg) by mouth every four hours as needed for pain.
Level of Harm - Minimal harm
or potential for actual harm
Review of the controlled substance scheduled drug record revealed 17 doses of the oxycodone
acetaminophen were pulled from the medication cards for one dose on 09/10/24, two doses on 09/11/24,
one dose on 09/12/24, one dose on 09/21/24, two doses on 09/22/24, one dose on 09/24/24, two doses on
09/26/24, one dose on 09/28/24, one dose on 09/29/24, one dose on 09/30/24, two dose on 10/01/24, one
dose on 10/02/24 and one dose on 10/09/24.
Residents Affected - Some
Review of the medication administration records from 09/01/24 through 10/09/24 revealed the 17 doses
pulled from the medication card were not documented as administered on the medication administration
record.
Interview on 10/22/24 at 3:46 P.M. RN #399 revealed controlled substances should be signed out in the
narcotic book when pulled and then documented on the medication administration record when
administered.
Interview on 10/22/24 at 3:53 P.M., Licensed Practical Nurse (LPN) #351 revealed controlled substances
should be signed out in the narcotic book then signed out on the medication administration record.
Interview on 10/23/24 at 11:40 A.M., the DON verified 17 doses of oxycodone/acetaminophen 10/325 mg
were pulled from the medication card and were not documented as administered in the medication
administration record.
3. Review of the medical record for Resident #84 revealed an admission date of 06/13/23. Diagnoses
included type two diabetes mellitus, osteoarthritis, and chronic kidney disease.
Review of the quarterly MDS assessment dated [DATE] revealed the resident had intact cognition.
Review of the physician orders dated 06/21/24 revealed orders for oxycodone oral capsule five milligrams
(mg) by mouth every six hours as needed for a pain level of eight to ten on a zero to ten scale.
Review of the controlled substance scheduled drug record revealed oxycodone was removed from the
medication card for one dose each on 09/17/24, 09/19/24, 09/23/24, 09/28/24, 10/16/24 and two doses on
09/26/24.
Review of the medication administration record revealed the medication pulled on 09/17/24, 09/19/24,
09/23/24, 09/28/24, 10/16/24 and 09/26/24 were not documented as administered on the medication
administration record.
Interview on 10/23/24 at 11:50 A.M., the DON verified seven doses of oxycodone were pulled from
Resident #84's medication card and never documented as administered in the medication administration
record.
4. Review of the medical record revealed Resident #117 had an admission date of 06/27/24 and a
discharge date of 07/17/24. Diagnoses include down syndrome, hydrocephalus, Barrett's esophagus, and
scoliosis.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366022
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366022
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/24/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Manor at Perrysburg
250 Manor Drive
Perrysburg, OH 43551
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Review of the five-day MDS assessment dated [DATE] revealed the resident had impaired cognition.
Level of Harm - Minimal harm
or potential for actual harm
Review of the physician orders dated 07/12/24 revealed an order for morphine sulfate 20 mg/milliliter (ml),
give 0.3 ml by mouth every one hour as needed for shortness of breath/pain.
Residents Affected - Some
Review of the medication administration record dated 07/01/24 through 07/17/24 revealed the resident was
administered the morphine sulfate once on 07/13/24, three times on 07/14/24, three times on 07/15/24, six
times on 07/16/24, and three times on 07/17/24.
Review of the medical record revealed there was no controlled substance scheduled drug record for
removal of the 16 doses of morphine sulfate.
Interview on 10/23/24 at 1:49 P.M., the DON verified the facility was unable to locate the controlled
substance record for morphine sulfate administered on 07/13/24 through 07/17/24 for Resident #117.
Review of the policy, Medication Administration General Guidelines, revised 03/20/18, revealed medication
were administered in accordance with written orders of the attending physician.
Review of policy, Order Procedure and Accountability for Controlled Medications, last revised 11/30/18,
revealed when a controlled medication dose was removed from control inventory, the licensed nurse
immediately documents the date and time of removal for administration, amount to be removed for
administration, signature of the nurse removing the medication dose on the proof-of-use sheet (Scheduled
Drug Record Form). Administration of the dose is also documented on the medication administration record
or the electronic medication record after the medication was administered.
This deficiency represents non-compliance investigated under Complaint Number OH00158689 and
Complaint Number OH00157665.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366022
If continuation sheet
Page 4 of 4